Clarus (CLAR) Q1 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2026 earnings summary
8 May, 2026Executive summary
Q1 2026 revenue grew 2.5% year-over-year to $61.9 million, with gross margin expanding by 240 basis points to 36.8%, reflecting disciplined execution and premium product positioning.
Net loss narrowed to $3.3 million from $5.2 million in Q1 2025, while adjusted net income reached $0.7 million versus an adjusted net loss of $1.2 million.
Strategic alternatives review initiated, including potential sale of all or part of the business, with Jefferies LLC retained as financial advisor; no set timetable.
Focus on simplification, core business execution, and cost reduction, with restructuring charges rising to $853,000.
Legal and regulatory expenses increased due to ongoing CPSC and DOJ matters.
Financial highlights
Q1 2026 consolidated sales were $61.9 million, up from $60.4 million in Q1 2025; domestic sales were $24.9 million (up 0.3%), international sales $37.1 million (up 4.0%).
Gross margin improved to 36.8% from 34.4% year-over-year; adjusted gross margin also rose to 36.8%.
Adjusted EBITDA was a $1.1 million loss (margin -1.8%), an improvement from $(1.4) million year-over-year.
Net loss for Q1 2026 was $(3.3) million, improved from $(5.2) million in Q1 2025; adjusted net income was $0.7 million, or $0.02 per diluted share.
Free cash flow was a $5.7 million outflow; cash and equivalents at quarter-end were $29.8 million, with no debt.
Outlook and guidance
Full-year 2026 sales guidance revised to $245–$255 million (down $10 million at midpoint, all from Adventure segment); adjusted EBITDA guidance lowered to $3–$5 million (from $9–$11 million), reflecting Adventure headwinds and legal costs.
Q2 2026 sales expected at $51–$53 million, with adjusted EBITDA loss of ~$3 million.
Full-year free cash flow now expected to be flat (prior: $3–$4 million); capex for 2026 projected at $6M–$7M.
Management expects further restructuring costs in 2026 as cost reduction actions continue.
Liquidity needs for the next 12 months are expected to be met with current cash and operating cash flows.
Latest events from Clarus
- Q3 sales dropped 17% but gross margin rose and debt was repaid after a major asset sale.CLAR
Q3 202424 Apr 2026 - 2024 margins and EBITDA improved despite lower sales; 2025 outlook targets growth amid risks.CLAR
Q4 202424 Apr 2026 - Q2 revenue fell, Adventure segment grew, and company remains debt-free with strong cash reserves.CLAR
Q2 202424 Apr 2026 - Proxy covers director elections, executive pay, auditor ratification, and governance practices.CLAR
Proxy filing24 Apr 2026 - 2025 sales and margins fell, but 2026 guidance targets EBITDA growth and debt-free stability.CLAR
Q4 20255 Mar 2026 - Key votes include director elections, auditor ratification, and a new stock incentive plan.CLAR
Proxy Filing1 Dec 2025 - Proxy supplement outlines major changes to the stock incentive plan and new proxy solicitor.CLAR
Proxy Filing1 Dec 2025 - Q1 sales dropped 13% and guidance was withdrawn amid macro and tariff uncertainty.CLAR
Q1 202521 Nov 2025 - Q2 sales fell 2%, net loss widened, and PIEPS divestiture advanced business simplification.CLAR
Q2 202516 Nov 2025